Increasing adiponectin via an apolipoprotein peptide mimetic, L-4F, increases bone formation in normal mice and prevents myeloma bone disease in vivo

Similar Items

• Decreased bone marrow-derived adiponectin contributes to myeloma pathogenesis in vivo
  by: Fowler, J, et al.
  Published: (2010)
• Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.
  by: Edwards, C, et al.
  Published: (2009)
• Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
  by: Edwards, C, et al.
  Published: (2008)
• Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.
  by: Fowler, J, et al.
  Published: (2011)
• Targeting Wnt signaling in myeloma in vivo; Differential effects on tumor burden and myeloma bone disease
  by: Edwards, C, et al.
  Published: (2007)